SynopsisThe global market for Lumpectomy was valued at US$ 1854 million in the year 2024 and is projected to reach a revised size of US$ 2881 million by 2031, growing at a CAGR of 6.6% during the forecast period. Women who’ve been recently diagnosed with breast .....
SynopsisThe global market for Anti-inflammatory Therapeutics was valued at US$ 124330 million in the year 2024 and is projected to reach a revised size of US$ 187100 million by 2031, growing at a CAGR of 6.1% during the forecast period. Anti-inflammatory therape.....
SynopsisThe global market for Trach Securement Devices was valued at US$ 51 million in the year 2024 and is projected to reach a revised size of US$ 67.5 million by 2031, growing at a CAGR of 3.5% during the forecast period. A Trach Securement Device is a medica.....
SynopsisThe global market for Peptide CXO was valued at US$ 3211 million in the year 2024 and is projected to reach a revised size of US$ 6459 million by 2031, growing at a CAGR of 10.6% during the forecast period. Peptide CXO refers to the outsourcing of resear.....
SynopsisThe global market for Prosthetic was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 16.5% during the forecast period. Prosthetic is a functional replacement for an ampu.....
SynopsisThe global market for Mitomycin was valued at US$ 191 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 8.4% during the forecast period. Mitomycin is an antibiotic which acts as a double-st.....
SynopsisThe global market for Dermal Fillers and Botulinum Toxin was valued at US$ 15960 million in the year 2024 and is projected to reach a revised size of US$ 31450 million by 2031, growing at a CAGR of 10.3% during the forecast period. Dermal Fillers are gel.....
SynopsisThe global market for Veterinary Obstetric and Gynecological Ultrasound Imager was valued at US$ 512 million in the year 2024 and is projected to reach a revised size of US$ 781 million by 2031, growing at a CAGR of 6.2% during the forecast period. Veter.....
SynopsisThe global market for Flavored Veterinary Medication was valued at US$ 3573 million in the year 2024 and is projected to reach a revised size of US$ 6601 million by 2031, growing at a CAGR of 9.3% during the forecast period. Flavoring veterinary drugs ar.....
SynopsisThe global market for Human Bone Morphogenetic Protein 9 was valued at US$ 98 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of 7.5% during the forecast period. Bone morphogenetic proteins .....
